CD7 CAR-T cell therapy(The General Hospital Of Western Theater Command)

N/A

Report date: 2024/09/06 20:00:43

Base Information

Drug NameCD7 CAR-T cell therapy(The General Hospital Of Western Theater Command)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionT lymphocyte replacementsT-cell antigen CD7 modulators

TargetsT-cell antigen CD7

Therapy Area/IndicationsLeukemia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaPhase 2 Clinical

Originator CompaniesThe General Hospital Of Western Theater Command

China Registration ClassN/A

Develop Information

Active CompaniesThe General Hospital Of Western Theater Command

Inactive CompaniesN/A

Active IndicationsLeukemia

Inactive IndicationsN/A

Other Information

ATC CodeN/A